Form 8-K - Current report:
SEC Accession No. 0001193125-25-081592
Filing Date
2025-04-15
Accepted
2025-04-15 16:48:23
Documents
22
Period of Report
2025-04-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d923668d8k.htm   iXBRL 8-K 43327
2 EX-1.1 d923668dex11.htm EX-1.1 193814
3 EX-4.1 d923668dex41.htm EX-4.1 58823
4 EX-4.2 d923668dex42.htm EX-4.2 78556
5 EX-5.1 d923668dex51.htm EX-5.1 13403
6 EX-99.1 d923668dex991.htm EX-99.1 11548
10 GRAPHIC g923668g01l51.jpg GRAPHIC 6231
11 GRAPHIC g923668g0415112319228.jpg GRAPHIC 2240
12 GRAPHIC g923668g0415112358364.jpg GRAPHIC 3288
13 GRAPHIC g923668g0415112358531.jpg GRAPHIC 2466
  Complete submission text file 0001193125-25-081592.txt   650376

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA cue-20250414.xsd EX-101.SCH 2863
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE cue-20250414_lab.xml EX-101.LAB 17236
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cue-20250414_pre.xml EX-101.PRE 10822
25 EXTRACTED XBRL INSTANCE DOCUMENT d923668d8k_htm.xml XML 3525
Mailing Address 40 GUEST STREET BOSTON MA 02135
Business Address 40 GUEST STREET BOSTON MA 02135 617-949-2680
Cue Biopharma, Inc. (Filer) CIK: 0001645460 (see all company filings)

EIN.: 473324577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38327 | Film No.: 25840186
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)